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3 flot) was achieved in 95% of the 2S group and 92% of the 1S group (p=0.66). Stent
thrombosis occurred in 5 patients (25%) of the 2S group at a median of 4.3 days, com-
pared to none (0%) of the 1S group (p< 0.001).
Conclusions: T-stenting of bifurcation lesions does not improve angiographic success
and is associated with a substantial risk of stent thrombosis.
1081-50 Predictors of Target Vessel Revascularization After 
Stenting Coronary Bifurcation Lesions: Insights From a 
Large Prospective Single-Center Database
Gunasekaran Sengottuvel, Thierry Lefèvre, André Kokis, Yves Louvard, Samer Mansour, 
Pierre Dumas, Mehran Monchi, Christophe Loubeyre, Oscar Tavolaro, Marie-Claude 
Morice, Institut Cardiovasculaire Paris Sud, Massy, France
Background: The use of stents is now the gold standard in the majority of coronary
lesions. However, use of bare stents in bifurcation lesions remains controversial.
Methods : We assessed the 7 months outcome and predictors of TVR from a large sin-
gle centre prospective database of patients with bifurcation lesions treated by stent. Fol-
low-up coronary angiogram was performed only in case of clinical or stress test ischemia.
Results: Between 1996-2002, 1149 patients underwent PCI and stent for bifurcation
lesion, age 65+9 years, 83% male, 37% unstable angina and 10% acute MI. The left
anterior descending bifurcation was involved in 53% of cases and distal left main in 8%.
Type B treatment (provisional T stenting of the side branch) was used in 74% of cases,
Type A (Systematic T stenting, the side branch first) in 18%, Type D (V stenting) in 6%
and Type C (Culotte) in 2%. The main branch (proximal reference diameter 3.1+0.5 mm)
was stented in 98.6 % of cases and the side branch (2.4+1.1 mm) in 37.2%. Angio-
graphic success (residual stenosis < 30%) was obtained in 96.3% of cases for the main
branch and 92.9 % for the side branch. The ischemic driven TVR rate at 7 months follow-
up was 13.2%. Predictors of TVR by univariate analysis were acute coronary syndrome
(12.3 vs 8.6%; OR 4.6, p = 0.001), period 1996-98 vs 1999-2002 (16.2 vs 11.8%; OR
0.67, p = 0.01), reference main branch diameter < 2.7 mm (18.8 vs 12.7%; OR 1.53, p =
0.065), non use of type B treatment (24.2 vs 11.0%; OR 0.48, p = 0.001), use of 2 stents
(19.1 vs 10.0%; OR 1.92, p = 0.001) and type 4 lesions compared to type 3 lesions (8.3
vs 22.1%; OR 4.6, p = 0.001). By multivariate analysis, independant predictors of 7-
months TVR were acute coronary syndromes (OR 6.74, p = 0.001, 95 % CI : 4.66 –
9.88), reference diameter < 2.7 mm (odds ratio 2.03, p = 0.006, 95 % CI : 1.22 – 2.38)
and non-use of type B treatment (odds ratio 0.46, p = 0.001, 95 % CI :0.31 – 0.67).
Conclusion: Stenting of bifurcation lesions is associated with a high rate of angiographic
success and an acceptable rate of ischemic driven TVR at 7 months. Independent pre-
dictors of TVR are acute coronary syndrome, small reference diameter and strategies
other than provisional T stenting
1081-51 AST SLK-View™: A Novel Approach for Treatment of 
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Cardiovascular Research Foundation and the Lenox Hill Heart and Vascular Institute, 
New York
Background. Treatment of bifurcation lesions is one of the main challenges of interven-
tional cardiology. Wile maintaining sufficient vessel support and side branch access,
SLK-View™ Stent offers a promising approach for the treatment of coronary bifurcation
lesions. The aim of this prospective, multicenter trial was to evaluate the safety and feasi-
bility of the SLK-View™ Stent for treatment of a de novo lesion that involves a major par-
ent coronary artery and side branch. Methods and Results. A total of 31 pts (67.7 % -
male; mean age 61.3±10 years) were treated. Follow-up included clinical assessment at
30 days and angiographic study at 6 months. The location of bifurcations was most fre-
quent in left descending artery/diagonal branch (84%), and was followed by right coro-
nary artery/posterior descending artery (10%) and circumflex/obtuse marginal branch
(6%). Stent was successfully delivered to bifurcations in all but 2 pts (93.5%). Procedural
success defined as <50% residual stenosis of the parent vessel in the absence of major
adverse cardiac events (MACE) was achieved in all pts with successful stent deployment.
Six-month MACE were observed in 14(45.1%) pts and were represented by target lesion
revascularization in the majority of pts (41.9%). Other results are presented in the Table.
Conclusions. SLK-View™ Stent is a safe and effective new solution for treatment of bifur-
cation lesions. Anti-restenosis drug elution should be considered in this high risk popula-
tion with this successful platform.
1081-52 Prediction of Death or Myocardial Infarction by Exercise 
SPECT Scintigraphy Among Patients Who Have Had 
Recent Coronary Stenting
Vivek Rajagopal, Hitinder S. Gurm, Richard C. Brunken, Claire E. Pothier, Deepak L. 
Bhatt, Michael S. Lauer, Cleveland Clinic Foundation, Cleveland, OH
Background: Although practice guidelines do not recommend routine exercise- testing
of patients after coronary stenting, several small studies have suggested that stress myo-
cardial perfusion imaging can provide prognostic information about future adverse car-
diac events.
Methods: We analyzed 420 patients who underwent dual isotope exercise nuclear scin-
tigraphy after coronary stenting between April 1996 and May 2002.Mild ischemia was
defined as reversible perfusion defects involving 6-18% of myocardial mass, while severe
ischemia involved more than 18% of myocardial mass. The primary endpoint was all-
cause mortality or myocardial infarction during a median of 12 months (range 1 to 60) of
follow-up.
Results: There were 101 patients (24%) who had mild or severe ischemia. Major events
(death or MI) occurred in 70 patients including 24 deaths. Among patients with no
ischemia the 1-year event rate was 6.2%, whereas among patients with mild or severe
ischemia, the event rates were 11.4% and 9.8% (P=0.006). After adjusting for age, gen-
der, standard cardiac risk factors, cardiac history, left ventricular ejection fraction, angio-
graphic findings, procedural variables, exercise capacity and heart rate dynamics, the
presence of scintigraphic evidence of ischemia predicted death or MI (adjusted hazard
ratio for 1 SD increase in mass of ischemic myocardium 1.37, 95% CI=1.11-1.68,
p=0.003). The presence of ischemia similarly predicted events in asymptomatic patients.
Conclusions: Among patients who have undergone recent coronary stent placement,
nuclear perfusion defects independently predicted risk of death or myocardial infarction.
1081-53 Debulking of Chronic Total Occlusions With Rotational 
or Directional Atherectomy Before Stenting Trial: A 
Multicenter Randomized Study
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Background: Previous randomized studies have shown that stenting reduces restenosis
and reocclusion rates of successfully recanalized chronic coronary total occlusions
(CTO) compared with balloon angioplasty (BA) alone, however the restenosis rate after
stenting still remains high. Calcified plaque or massive plaque burden in CTO is consid-
ered to interfere with full stent expansion and be a cause of restenosis. Methods: DOC-
TORS (Debulking Of CTO with Rotational or directional atherectomy before Stenting) is a
multicenter randomized trial aimed to examine the efficacy of pre-stent plaque debulking
by rotational or directional atherectomy (RA/DCA) on reduction of restenosis. After suc-
cessful recanalization of CTO (TIMI flow =< 1, estimated occlusive duration >= 1 month)
by using a conventional wire, the physician determined the indication of RA or DCA.
Then, patients were randomly assigned to the debulking (D) group or the non-debulking
(ND) group according to the debulking device the physician decided. In the D group, RA
or DCA was performed and stents were implanted to fully cover the lesion. In the ND
group, stents were implanted after conventional BA. Serial quantitative angiography
(QCA) and intravascular ultrasound (IVUS) examination were performed at the procedure
and 6 month follow-up (Fu). The primary endpoint was the angiographic restenosis rate.
Secondary endpoints were clinical outcomes by 1 year and QCA and IVUS parameters.
Results: In Japanese 21 centers, 271 patients were enrolled (~ July 2003). Of those, 138
patients were assigned to the D (RA: 90, DCA: 48) and 133 to the ND group. Baseline
characteristics did not differ. There were 4 unsuccessful cases; 3 in the D and 1 in the ND
group (NS). Major adverse cardiac event rate by 30 days was also similar (1.6% versus
0%). Total implanted stent length was significantly longer in the ND group (25.7±10.8 ver-
sus 28.8±12.0 mm; p=0.03). Fu angiographic data has been collected in 197 patients to
date. Target vessel revascularization rate was higher in the ND group (26.8 versus
41.2%; p=0.04). Conclusion: Pre-stent debulking for CTO is safe and may be effective in
prevention of restenosis. Final Fu angiographic results and QCA data will be presented.
1081-54 Effect of Diabetes on Five-Year Outcomes After 
Coronary Stent Implantation
Donald E. Cutlip, Manish S. Chauhan, David R. Holmes, Julian M. Aroesty, Amit 
Chhabra, Ralph A. D'Agostino, Joseph P. Carrozza, Jr., Kalon K.L. Ho, Harvard Clinical 
Research Institute, Boston, MA, Beth Israel Deaconess Medical Center, Boston, MA
Background: Diabetes (DM) is associated with significantly increased clinical restenosis
in the first year after coronary stenting. The DM effect on target lesion stability after one
year and long-term overall cardiac clinical outcome after second-generation coronary
stents has not been reported. Methods: We reviewed clinical outcomes for a subset of
patients consented for long-term follow-up as part of pivotal stent trials evaluated for FDA
approval. We report pooled data for 1228 such patients with mean 4.4 years follow-up. A
Cox proportional hazards model was used to evaluate the independent effect of diabetes
on overall mortality and the 5-year composite cardiac event rate. Results: DM patients
were older (64 ± 10 vs. 62 ± 11 years, p=0.008), more frequently women (41% vs. 29%,
p=0.001) and had more frequent 3 vessel disease (11.4% vs. 7.1%, p=0.02). At one year,
target lesion revascularization (TLR) was significantly more common for DM (Table). Dur-
ing years 2-5, TLR was infrequent in either group, but the incidence of ischemic events
and death was increased among DM patients. DM was a significant independent predic-
tor of the 5-year composite outcome (Hazard Ratio 1.5, p=0.0001). Conclusions: 1) Dia-
betes was not associated with increased TLR after one year. 2) Despite similar stability of
Quantitative Angiographic Data at Baseline and 6-Month Follow-up
Characteristic Parent vessel Branch vessel
Pre-PCI Post-PCI At 6 
months
Pre-PCI Post-PCI At 6 
months
Reference vessel 
diameter, mm
2.9±0.4 - - 2.2±0.4 - -
Minimal lumen 
diameter, mm
1.1±0.4 2.3±0.5 1.51±0.76 1.4±0.4 1.7±0.4 1.2±0.6
Percent stenosis, 
%
63.1±12.8 23.5±8.0 49.0±22 37.7±16.7 24.2±13.5 41±26
Vessel with 
percent 
stenosis<50%, n 
(%)
- 29 
(100%)
12 (48%) - - 8 (32%)
